July 3, 2023 Comments Off on New tentative approval for Mylan Labs drug posaconazole Posted in: Tentative Approval [](//www.DrugPatentWatch.com/p/preview/generic-api/posaconazole?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Posaconazole is the ge…
July 3, 2023 Comments Off on New patent expiration for Bayer Hlthcare drug LEVITRA Posted in: Uncategorized
Annual Drug Patent Expirations for LEVITRA Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug and three Paragraph…
The post New patent expiration for Bayer Hlthcare drug LEVITRA appeared …
